{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:15:45Z","timestamp":1787796945632,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johannes Gutenberg-Universit\u00e4t Mainz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-026-03377-8","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:26:12Z","timestamp":1772835972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Solubility-Permeability-Matrix Interplay in Percutaneous Absorption Exemplified by Theophylline"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3817-6225","authenticated-orcid":false,"given":"Sophia","family":"Engel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7994-4175","authenticated-orcid":false,"given":"Jozef","family":"Al-Gousous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4278-6896","authenticated-orcid":false,"given":"Christiane","family":"Gr\u00fcnewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-3950","authenticated-orcid":false,"given":"Claire","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3758-7581","authenticated-orcid":false,"given":"Peter","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"3377_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12070684","volume":"12","author":"C Gorzelanny","year":"2020","unstructured":"Gorzelanny C, Mess C, Schneider SW, Huck V, Brandner JM. Skin barriers in dermal drug delivery: which barriers have to be overcome and how can we measure them? Pharmaceutics. 2020;12: 684. https:\/\/doi.org\/10.3390\/pharmaceutics12070684.","journal-title":"Pharmaceutics"},{"key":"3377_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/J.IJPHARM.2012.06.005","volume":"435","author":"GK Menon","year":"2012","unstructured":"Menon GK, Cleary GW, Lane ME. The structure and function of the stratum corneum. Int J Pharm. 2012;435:3\u20139. https:\/\/doi.org\/10.1016\/J.IJPHARM.2012.06.005.","journal-title":"Int J Pharm"},{"key":"3377_CR3","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/AIC.690210522","volume":"21","author":"AS Michaels","year":"1975","unstructured":"Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory and in vitro experimental measurement. AIChE J. 1975;21:985\u201396. https:\/\/doi.org\/10.1002\/AIC.690210522.","journal-title":"AIChE J"},{"key":"3377_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/1523-1747.EP12470383","volume":"88","author":"DC Swartzendruber","year":"1987","unstructured":"Swartzendruber DC, Wertz PW, Madison KC, Downing DT. Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol. 1987;88:709\u201313. https:\/\/doi.org\/10.1111\/1523-1747.EP12470383.","journal-title":"J Invest Dermatol"},{"key":"3377_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS25010236","volume":"25","author":"N Pondeljak","year":"2024","unstructured":"Pondeljak N, Lugovi\u0107-Mihi\u0107 L, Tomi\u0107 L, Para\u0107 E, Pedi\u0107 L, Lazi\u0107-Mosler E. Key factors in the complex and coordinated network of skin keratinization: their significance and involvement in common skin conditions. Int J Mol Sci. 2024;25: 236. https:\/\/doi.org\/10.3390\/IJMS25010236.","journal-title":"Int J Mol Sci"},{"key":"3377_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/000155500750042826","volume":"208","author":"JA Bouwstra","year":"2000","unstructured":"Bouwstra JA, Dubbelaar FER, Gooris GS, Ponec M. The lipid organisation in the skin barrier. Acta Derm Venereol Suppl (Stockh). 2000;208:23\u201330. https:\/\/doi.org\/10.1080\/000155500750042826.","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"3377_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/J.1523-1747.2003.12103.X","volume":"120","author":"M Ponec","year":"2003","unstructured":"Ponec M, Weerheim A, Lankhorst P, Wertz P. New acylceramide in native and reconstructed epidermis. J Invest Dermatol. 2003;120:581\u20138. https:\/\/doi.org\/10.1046\/J.1523-1747.2003.12103.X.","journal-title":"J Invest Dermatol"},{"key":"3377_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/J.COLSURFB.2021.111748","volume":"203","author":"M Elmowafy","year":"2021","unstructured":"Elmowafy M. Skin penetration\/permeation success determinants of nanocarriers: pursuit of a perfect formulation. Colloids Surf B Biointerfaces. 2021;203: 111748. https:\/\/doi.org\/10.1016\/J.COLSURFB.2021.111748.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3377_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1773-2247(14)50041-X","volume":"24","author":"KB Ita","year":"2014","unstructured":"Ita KB. Transdermal drug delivery: progress and challenges. J Drug Deliv Sci Technol. 2014;24:245\u201350. https:\/\/doi.org\/10.1016\/S1773-2247(14)50041-X.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3377_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/J.JCONREL.2014.05.022","volume":"190","author":"S Wiedersberg","year":"2014","unstructured":"Wiedersberg S, Guy RH. Transdermal drug delivery: 30 + years of war and still fighting! J Control Release. 2014;190:150\u20136. https:\/\/doi.org\/10.1016\/J.JCONREL.2014.05.022.","journal-title":"J Control Release"},{"key":"3377_CR11","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/JPS.2600830424","volume":"83","author":"CK Lee","year":"1994","unstructured":"Lee CK, Uchida T, Kitagawa K, Yagi A, Kim N-S, Goto S. Skin permeability of various drugs with different lipophilicity. J Pharm Sci. 1994;83:562\u20135. https:\/\/doi.org\/10.1002\/JPS.2600830424.","journal-title":"J Pharm Sci"},{"key":"3377_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd1304","volume":"3","author":"MR Prausnitz","year":"2004","unstructured":"Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115\u201324. https:\/\/doi.org\/10.1038\/nrd1304.","journal-title":"Nat Rev Drug Discov"},{"key":"3377_CR13","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/S11095-010-0292-6","volume":"28","author":"YB Choy","year":"2011","unstructured":"Choy YB, Prausnitz MR. The rule of five for non-oral routes of drug delivery: ophthalmic, inhalation and transdermal. Pharm Res. 2011;28:943\u20138. https:\/\/doi.org\/10.1007\/S11095-010-0292-6.","journal-title":"Pharm Res"},{"key":"3377_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/J.1467-2494.1988.TB00028.X","volume":"10","author":"BW Barry","year":"1988","unstructured":"Barry BW. Action of skin penetration enhancers\u2014the lipid protein partitioning theory. Int J Cosmet Sci. 1988;10:281\u201393. https:\/\/doi.org\/10.1111\/J.1467-2494.1988.TB00028.X.","journal-title":"Int J Cosmet Sci"},{"key":"3377_CR15","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nbt.1504","volume":"26","author":"MR Prausnitz","year":"2008","unstructured":"Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261\u20138. https:\/\/doi.org\/10.1038\/nbt.1504.","journal-title":"Nat Biotechnol"},{"key":"3377_CR16","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1111\/BPH.13059","volume":"172","author":"MN Pastore","year":"2015","unstructured":"Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015;172:2179\u2013209. https:\/\/doi.org\/10.1111\/BPH.13059.","journal-title":"Br J Pharmacol"},{"key":"3377_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/J.1479-828X.2000.TB03341.X","volume":"40","author":"Y Lake","year":"2000","unstructured":"Lake Y, Pinnock S. Improved patient acceptability with a transdermal drug-in-adhesive oestradiol patch. Aust N Z J Obstet Gynaecol. 2000;40:313\u20136. https:\/\/doi.org\/10.1111\/J.1479-828X.2000.TB03341.X.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"3377_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/PR11092673","volume":"11","author":"W Wu","year":"2023","unstructured":"Wu W, Lu Y, De Marco I. Transdermal patches containing opioids in the treatment of patients with chronic pain. Processes. 2023;11: 2673. https:\/\/doi.org\/10.3390\/PR11092673.","journal-title":"Processes"},{"key":"3377_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/PH17101346","volume":"17","author":"D Sivadasan","year":"2024","unstructured":"Sivadasan D, Madkhali OA. The design features, quality by design approach, characterization, therapeutic applications, and clinical considerations of transdermal drug delivery systems\u2014a comprehensive review. Pharmaceuticals. 2024;17: 1346. https:\/\/doi.org\/10.3390\/PH17101346.","journal-title":"Pharmaceuticals"},{"key":"3377_CR20","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.21037\/JTD-23-1781","volume":"16","author":"M Scurek","year":"2024","unstructured":"Scurek M, Brat K. A narrative review of theophylline: is there still a place for an old friend? J Thorac Dis. 2024;16:3450\u201360. https:\/\/doi.org\/10.21037\/JTD-23-1781.","journal-title":"J Thorac Dis"},{"key":"3377_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2165\/00002018-199005040-00004","volume":"5","author":"MH Skinner","year":"1990","unstructured":"Skinner MH. Adverse reactions and interactions with theophylline. Drug Saf. 1990;5:275\u201385. https:\/\/doi.org\/10.2165\/00002018-199005040-00004.","journal-title":"Drug Saf"},{"key":"3377_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/PH3030725","volume":"3","author":"PJ Barnes","year":"2010","unstructured":"Barnes PJ. Theophylline. Pharmaceuticals. 2010;3:725\u201347. https:\/\/doi.org\/10.3390\/PH3030725.","journal-title":"Pharmaceuticals"},{"key":"3377_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1365-2125.1981.tb00533.x","volume":"11","author":"A Aslaksen","year":"1981","unstructured":"Aslaksen A, Bakke O, Vigander T. Comparative pharmacokinetics of theophylline and aminophylline in man. Br J Clin Pharmacol. 1981;11:269\u201373. https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb00533.x.","journal-title":"Br J Clin Pharmacol"},{"key":"3377_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1164\/RCCM.201302-0388PP","volume":"188","author":"PJ Barnes","year":"2013","unstructured":"Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2013;188:901\u20136. https:\/\/doi.org\/10.1164\/RCCM.201302-0388PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"3377_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1021\/MP0601345","volume":"4","author":"SL Childs","year":"2007","unstructured":"Childs SL, Stahly GP, Park A. The salt-cocrystal continuum: the influence of crystal structure on ionization state. Mol Pharm. 2007;4:323\u201338. https:\/\/doi.org\/10.1021\/MP0601345.","journal-title":"Mol Pharm"},{"key":"3377_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10061418","volume":"10","author":"M Duman","year":"2022","unstructured":"Duman M, Jaggi S, Enz LS, Jacob C, Schaeren-Wiemers N. Theophylline induces remyelination and functional recovery in a mouse model of peripheral neuropathy. Biomedicines. 2022;10: 1418. https:\/\/doi.org\/10.3390\/biomedicines10061418.","journal-title":"Biomedicines"},{"key":"3377_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17243-z","volume":"11","author":"M Duman","year":"2020","unstructured":"Duman M, Vaqui\u00e9 A, Nocera G, Heller M, Stumpe M, Siva Sankar D, et al. EEF1A1 deacetylation enables transcriptional activation of remyelination. Nat Commun. 2020;11: 3420. https:\/\/doi.org\/10.1038\/s41467-020-17243-z.","journal-title":"Nat Commun"},{"key":"3377_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1164\/rccm.200210-1142PP","volume":"167","author":"PJ Barnes","year":"2003","unstructured":"Barnes PJ. Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med. 2003;167:813\u20138. https:\/\/doi.org\/10.1164\/rccm.200210-1142PP.","journal-title":"Am J Respir Crit Care Med"},{"key":"3377_CR29","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1248\/CPB.46.1428","volume":"46","author":"RM Hanif","year":"1998","unstructured":"Hanif RM, Qineng P, Fenzhu M. Synthesis and effect of two new penetration enhancers on the transdermal delivery of 5-fluorouracil through excised rat skin. Chem Pharm Bull (Tokyo). 1998;46:1428\u201331. https:\/\/doi.org\/10.1248\/CPB.46.1428.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"3377_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ejpb.2022.11.004","volume":"181","author":"A Boix-Monta\u00f1\u00e9s","year":"2022","unstructured":"Boix-Monta\u00f1\u00e9s A, Celma-Lezcano C, Obach-Vidal R, Peraire-Guitart C. Collaborative permeation of drug and excipients in transdermal formulations. In vitro scrutiny for ethanol:limonene combinations. Eur J Pharm Biopharm. 2022;181:239\u201348. https:\/\/doi.org\/10.1016\/j.ejpb.2022.11.004.","journal-title":"Eur J Pharm Biopharm"},{"key":"3377_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/J.EJPS.2010.03.008","volume":"40","author":"RM Hathout","year":"2010","unstructured":"Hathout RM, Woodman TJ, Mansour S, Mortada ND, Geneidi AS, Guy RH. Microemulsion formulations for the transdermal delivery of testosterone. Eur J Pharm Sci. 2010;40:188\u201396. https:\/\/doi.org\/10.1016\/J.EJPS.2010.03.008.","journal-title":"Eur J Pharm Sci"},{"key":"3377_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0939-6411(01)00215-6","volume":"53","author":"DA Godwin","year":"2002","unstructured":"Godwin DA, Kim NH, Felton LA. Influence of Transcutol\u00ae CG on the skin accumulation and transdermal permeation of ultraviolet absorbers. Eur J Pharm Biopharm. 2002;53:23\u20137. https:\/\/doi.org\/10.1016\/S0939-6411(01)00215-6.","journal-title":"Eur J Pharm Biopharm"},{"key":"3377_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000029928","volume":"13","author":"GA Simon","year":"2000","unstructured":"Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol Appl Skin Physiol. 2000;13:229\u201334. https:\/\/doi.org\/10.1159\/000029928.","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"key":"3377_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0846.2006.00179.x","volume":"13","author":"U Jacobi","year":"2007","unstructured":"Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, et al. Porcine ear skin: an in vitro model for human skin. Skin Res Technol. 2007;13:19\u201324. https:\/\/doi.org\/10.1111\/j.1600-0846.2006.00179.x.","journal-title":"Skin Res Technol"},{"key":"3377_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00018","volume":"9","author":"B Pavan","year":"2018","unstructured":"Pavan B, Dalpiaz A, Marani L, Beggiato S, Ferraro L, Canistro D, et al. Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes. Front Pharmacol. 2018;9: 18. https:\/\/doi.org\/10.3389\/fphar.2018.00018.","journal-title":"Front Pharmacol"},{"key":"3377_CR36","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jhrc.1240150507","volume":"15","author":"G Bonetti","year":"1992","unstructured":"Bonetti G, Pibarot P, Chaintreau A, Marion JP. Quantitation of diethylene glycol monoethyl ether in citrus oils. J High Resolut Chromatogr. 1992;15:305\u20136. https:\/\/doi.org\/10.1002\/jhrc.1240150507.","journal-title":"J High Resolut Chromatogr"},{"key":"3377_CR37","unstructured":"International Agency for Research on Cancer. Theophylline. In: Coffee, Tea, Mate, Methylxanthines and Methylglyoxal. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 51. Lyon, France: IARC; 1991. p. 391\u2013419."},{"key":"3377_CR38","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/1520-6017(200012)89:12<1620::aid-jps13>3.0.co;2-n","volume":"89","author":"N Ni","year":"2000","unstructured":"Ni N, El-Sayed MM, Sanghvi T, Yalkowsky SH. Estimation of the effect of NaCl on the solubility of organic compounds in aqueous solutions. J Pharm Sci. 2000;89:1620\u20135. https:\/\/doi.org\/10.1002\/1520-6017(200012)89:12%3c1620::aid-jps13%3e3.0.co;2-n.","journal-title":"J Pharm Sci"},{"key":"3377_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/03639040600901994","volume":"33","author":"RA Thakur","year":"2007","unstructured":"Thakur RA, Michniak BB, Meidan VM. Transdermal and buccal delivery of methylxanthines through human tissue in vitro. Drug Dev Ind Pharm. 2007;33:513\u201321. https:\/\/doi.org\/10.1080\/03639040600901994.","journal-title":"Drug Dev Ind Pharm"},{"key":"3377_CR40","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1081\/DDC-100108368","volume":"27","author":"SN Murthy","year":"2001","unstructured":"Murthy SN, Rani S, Hiremath R. Formulation and evaluation of controlled-release transdermal patches of theophylline-salbutamol sulfate. Drug Dev Ind Pharm. 2001;27:1057\u201362. https:\/\/doi.org\/10.1081\/DDC-100108368.","journal-title":"Drug Dev Ind Pharm"},{"key":"3377_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/J.1365-2125.1990.TB03676.X","volume":"29","author":"R Cartwright","year":"1990","unstructured":"Cartwright R, Cartlidge P, Rutter N, Melia C, Davis S. Transdermal delivery of theophylline to premature infants using a hydrogel disc system. Br J Clin Pharmacol. 1990;29:533\u20139. https:\/\/doi.org\/10.1111\/J.1365-2125.1990.TB03676.X.","journal-title":"Br J Clin Pharmacol"},{"key":"3377_CR42","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0378-5173(85)90025-0","volume":"24","author":"N Evans","year":"1985","unstructured":"Evans N, Guy RH, Hadgraft J, Parr GD, Rutter N. Transdermal drug delivery to neonates. Int J Pharm. 1985;24:259\u201365. https:\/\/doi.org\/10.1016\/0378-5173(85)90025-0.","journal-title":"Int J Pharm"},{"key":"3377_CR43","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/J.1468-2494.2007.00405_4.x","volume":"58","author":"LH Wang","year":"2007","unstructured":"Wang LH, Wang CC, Kuo SC. Vehicle and enhancer effects on human skin penetration of aminophylline from cream formulations: evaluation in vivo. J Cosmet Sci. 2007;58:245\u201354. https:\/\/doi.org\/10.1111\/J.1468-2494.2007.00405_4.x.","journal-title":"J Cosmet Sci"},{"key":"3377_CR44","doi-asserted-by":"publisher","DOI":"10.17795\/JJNPP-12904","volume":"9","author":"M Kouchak","year":"2014","unstructured":"Kouchak M, Handali S. Effects of various penetration enhancers on penetration of aminophylline through shed snake skin. Jundishapur J Nat Pharm Prod. 2014;9: 24. https:\/\/doi.org\/10.17795\/JJNPP-12904.","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"3377_CR45","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1081\/DDC-100102251","volume":"25","author":"DA Godwin","year":"1999","unstructured":"Godwin DA, Michniak BB. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm. 1999;25:905\u201315. https:\/\/doi.org\/10.1081\/DDC-100102251.","journal-title":"Drug Dev Ind Pharm"},{"key":"3377_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0378-5173(93)90023-9","volume":"94","author":"PA Cornwell","year":"1993","unstructured":"Cornwell PA, Barry BW. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int J Pharm. 1993;94:189\u201394. https:\/\/doi.org\/10.1016\/0378-5173(93)90023-9.","journal-title":"Int J Pharm"},{"key":"3377_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1248\/CPB.C22-00568","volume":"71","author":"Q Xu","year":"2023","unstructured":"Xu Q, Wu Y, Saito H, Ofuchi Y, Setoyama H, Furuishi T, et al. Promoting activity of terpenes on skin permeation of famotidine. Chem Pharm Bull. 2023;71:111\u20139. https:\/\/doi.org\/10.1248\/CPB.C22-00568.","journal-title":"Chem Pharm Bull"},{"key":"3377_CR48","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/J.JCONREL.2016.04.030","volume":"232","author":"QD Pham","year":"2016","unstructured":"Pham QD, Bj\u00f6rklund S, Engblom J, Topgaard D, Sparr E. Chemical penetration enhancers in stratum corneum \u2014 relation between molecular effects and barrier function. J Control Release. 2016;232:175\u201387. https:\/\/doi.org\/10.1016\/J.JCONREL.2016.04.030.","journal-title":"J Control Release"},{"key":"3377_CR49","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1021\/acs.jcim.3c00625","volume":"63","author":"C Wennberg","year":"2023","unstructured":"Wennberg C, Lundborg M, Lindahl E, Norl\u00e9n L. Understanding drug skin permeation enhancers using molecular dynamics simulations. J Chem Inf Model. 2023;63:4900\u201311. https:\/\/doi.org\/10.1021\/acs.jcim.3c00625.","journal-title":"J Chem Inf Model"},{"key":"3377_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/S12249-024-02886-8","volume":"25","author":"J Musakhanian","year":"2024","unstructured":"Musakhanian J, Osborne DW, Rodier JD. Skin penetration and permeation properties of Transcutol\u00ae in complex formulations. AAPS PharmSciTech. 2024;25:1\u201323. https:\/\/doi.org\/10.1208\/S12249-024-02886-8.","journal-title":"AAPS PharmSciTech"},{"key":"3377_CR51","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1208\/S12249-018-1196-8","volume":"19","author":"DW Osborne","year":"2018","unstructured":"Osborne DW, Musakhanian J. Skin penetration and permeation properties of Transcutol\u00ae\u2014neat or diluted mixtures. AAPS PharmSciTech. 2018;19:3512\u201333. https:\/\/doi.org\/10.1208\/S12249-018-1196-8.","journal-title":"AAPS PharmSciTech"},{"key":"3377_CR52","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1023\/A:1016037803128","volume":"13","author":"JE Harrison","year":"1996","unstructured":"Harrison JE, Watkinson AC, Green DM, Hadgraft J, Brain K. The relative effect of azone\u00ae and transcutol\u00ae on permeant diffusivity and solubility in human stratum corneum. Pharm Res. 1996;13:542\u20136. https:\/\/doi.org\/10.1023\/A:1016037803128.","journal-title":"Pharm Res"},{"key":"3377_CR53","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/1523-1747.EP12470197","volume":"96","author":"RO Potts","year":"1991","unstructured":"Potts RO, Francoeur ML. The influence of stratum corneum morphology on water permeability. J Invest Dermatol. 1991;96:495\u20139. https:\/\/doi.org\/10.1111\/1523-1747.EP12470197.","journal-title":"J Invest Dermatol"},{"key":"3377_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/J.IJPHARM.2006.09.043","volume":"333","author":"KY Ho","year":"2007","unstructured":"Ho KY, Dodou K. Rheological studies on pressure-sensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance. Int J Pharm. 2007;333:24\u201333. https:\/\/doi.org\/10.1016\/J.IJPHARM.2006.09.043.","journal-title":"Int J Pharm"},{"key":"3377_CR55","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.3390\/POLYM15224355","volume":"15","author":"B Maciejewski","year":"2023","unstructured":"Maciejewski B, D\u0142abiszewska J, Mikolaszek B, Sznitowska M. The impact of liquid components on alteration of the adhesion of polyacrylate and silicone patches. Polymers (Basel). 2023;15:4355. https:\/\/doi.org\/10.3390\/POLYM15224355.","journal-title":"Polymers (Basel)"},{"key":"3377_CR56","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1208\/S12249-008-9181-2","volume":"10","author":"S Missaghi","year":"2009","unstructured":"Missaghi S, Fegely KA, Rajabi-Siahboomi AR. Investigation of the effects of hydroalcoholic solutions on textural and rheological properties of various controlled release grades of hypromellose. AAPS PharmSciTech. 2009;10:77\u201380. https:\/\/doi.org\/10.1208\/S12249-008-9181-2.","journal-title":"AAPS PharmSciTech"},{"key":"3377_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/J.FLUID.2015.02.018","volume":"392","author":"A Pobudkowska","year":"2015","unstructured":"Pobudkowska A, Doma\u0144ska U, Jurkowska BA, Dymczuk K. Solubility of pharmaceuticals in water and alcohols. Fluid Phase Equilib. 2015;392:56\u201364. https:\/\/doi.org\/10.1016\/J.FLUID.2015.02.018.","journal-title":"Fluid Phase Equilib"},{"key":"3377_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-2494.2008.00467.x","volume":"31","author":"A Otto","year":"2009","unstructured":"Otto A, Du Plessis J, Wiechers JW. Formulation effects of topical emulsions on transdermal and dermal delivery. Int J Cosmet Sci. 2009;31:1\u201319. https:\/\/doi.org\/10.1111\/j.1468-2494.2008.00467.x.","journal-title":"Int J Cosmet Sci"},{"key":"3377_CR59","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1021\/acs.jced.7b00065","volume":"62","author":"J Zhong","year":"2017","unstructured":"Zhong J, Tang N, Asadzadeh B, Yan W. Measurement and correlation of solubility of theobromine, theophylline, and caffeine in water and organic solvents at various temperatures. J Chem Eng Data. 2017;62:2570\u20137. https:\/\/doi.org\/10.1021\/acs.jced.7b00065.","journal-title":"J Chem Eng Data"},{"key":"3377_CR60","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.JCONREL.2004.09.016","volume":"102","author":"STK Narishetty","year":"2005","unstructured":"Narishetty STK, Panchagnula R. Effect of l-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine. J Control Release. 2005;102:59\u201370. https:\/\/doi.org\/10.1016\/J.JCONREL.2004.09.016.","journal-title":"J Control Release"},{"key":"3377_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijpharm.2011.02.023","volume":"418","author":"S Mitragotri","year":"2011","unstructured":"Mitragotri S, Anissimov YG, Bunge AL, Frasch HF, Guy RH, Hadgraft J, et al. Mathematical models of skin permeability: an overview. Int J Pharm. 2011;418:115\u201329. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.02.023.","journal-title":"Int J Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03377-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-026-03377-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-026-03377-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:52:01Z","timestamp":1780390321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-026-03377-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["3377"],"URL":"https:\/\/doi.org\/10.1208\/s12249-026-03377-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patent application \u201cA transdermal patch for promoting or accelerating myelination and\/or remyelination\u201d, European Patent Application n\u00b0 EP22195291, International Patent Application n\u00b0 PCT\/EP2023\/074981.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"131"}}